Carderock Capital Management Inc. lifted its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 15.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 24,465 shares of the conglomerate’s stock after purchasing an additional 3,362 shares during the quarter. Carderock Capital Management Inc.’s holdings in Danaher were worth $5,601,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Kestra Private Wealth Services LLC grew its stake in Danaher by 0.3% during the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after buying an additional 48 shares in the last quarter. Norway Savings Bank increased its holdings in Danaher by 0.7% in the 4th quarter. Norway Savings Bank now owns 7,063 shares of the conglomerate’s stock valued at $1,617,000 after buying an additional 49 shares during the period. SOL Capital Management CO raised its position in shares of Danaher by 2.8% in the 3rd quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock valued at $363,000 after buying an additional 50 shares in the last quarter. Purkiss Capital Advisors LLC raised its position in shares of Danaher by 3.9% in the 3rd quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock valued at $263,000 after buying an additional 50 shares in the last quarter. Finally, TCTC Holdings LLC lifted its holdings in shares of Danaher by 0.7% during the 3rd quarter. TCTC Holdings LLC now owns 7,439 shares of the conglomerate’s stock worth $1,475,000 after acquiring an additional 51 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Buying and Selling
In other news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 11.20% of the company’s stock.
Danaher Stock Performance
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. During the same period in the prior year, the business earned $2.14 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. On average, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is currently 25.40%.
Analysts Set New Price Targets
A number of research analysts recently issued reports on the stock. Jefferies Financial Group lifted their price objective on shares of Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. TD Cowen reaffirmed a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. Robert W. Baird set a $251.00 price target on Danaher in a research note on Thursday, January 29th. Wells Fargo & Company boosted their price target on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Finally, The Goldman Sachs Group reduced their price objective on Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $253.55.
Read Our Latest Stock Analysis on Danaher
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
